The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates
Open accessAbstract
Mammalian cells possess mechanisms to detect and defend themselves from invading viruses. In the cytosol, the RIG-I-like receptors (RLRs), RIG-I (retinoic acid-inducible gene I; encoded by DDX58) and MDA5 (melanoma differentiation-associated gene 5; encoded by IFIH1) sense atypical RNAs associated with virus infection. Detection triggers a signalling cascade via the adaptor MAVS that culminates in the production of type I interferons (IFN-α and β; hereafter IFN), which are key antiviral cytokines. RIG-I and MDA5 are activated by distinct viral RNA structures and much evidence indicates that RIG-I responds to RNAs bearing a triphosphate (ppp) moiety in conjunction with a blunt-ended, base-paired region at the 5'-end (reviewed in refs 1, 2, 3). Here we show that RIG-I also mediates antiviral responses to RNAs bearing 5'-diphosphates (5'pp). Genomes from mammalian reoviruses with 5'pp termini, 5'pp-RNA isolated from yeast L-A virus, and base-paired 5'pp-RNAs made by in vitro transcription or chemical synthesis, all bind to RIG-I and serve as RIG-I agonists. Furthermore, a RIG-I-dependent response to 5'pp-RNA is essential for controlling reovirus infection in cultured cells and in mice. Thus, the minimal determinant for RIG-I recognition is a base-paired RNA with 5'pp. Such RNAs are found in some viruses but not in uninfected cells, indicating that recognition of 5'pp-RNA, like that of 5'ppp-RNA, acts as a powerful means of self/non-self discrimination by the innate immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through recognition of TLR3 in endosomes or retinoic acid-inducible gene I, melanoma differentiation-associated protein 5, and inflammasomes in the cytoplasm,96, 97, 98, 99 depending on the amount, dsRNAs might overactivate innate immunity and lead to adverse events.”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,741
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
CGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING.
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., Hopfner, K.-P., Ludwig, J., & Hornung, V. (2013) · Nature · doi:10.1038/nature12306 · Cited by 1,695
Kato, H., Takeuchi, O., Mikamo, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T., & Akira, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080091 · Cited by 1,649
Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity
Loo, Y.-M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M. A., García-Sastre, A., Katze, M. G., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01080-07 · Cited by 1,071
Goubau, D., Deddouche, S., & Sousa, C. R. E. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 875
Schlee, M., Roth, A. H. F. J., Hornung, V., Hagmann, C. A., Wimmenauer, V., Barchet, W., Coch, C., Janke, M., Mihailovic, A., Wardle, G. S., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.008 · Cited by 814
RIG-I detects viral genomic RNA during negative-strand RNA virus infection
Rehwinkel, J., Tan, C. P., Goubau, D., Schulz, O., Pichlmair, A., Bier, K., Robb, N., Vreede, F., Barclay, W., Fodor, E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.020 · Cited by 585
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers
Diebold, S. S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al‐Shamkhani, A., Flavell, R. A., Borrow, P., & Sousa, C. R. E. (2003) · Nature · doi:10.1038/nature01783 · Cited by 582
Flagged first, then by citations
Research works printed but not linked: 1
- Dermody, T. S., Sherry, B. & Parker, J. S. L. in Fields Virology 6th edn ( Knipe, D. M. & Howley, P. M. ) 2, 1304–1346 (Wolters Kluwer Health/Lippincott Williams & Wilkins, 2013)
Cited by
Sorted by citations
Items 301–400 of 556
Mohamed, A., Konda, P., Eaton, H. E., Gujar, S. A., Smiley, J. R., & Shmulevitz, M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008803 · Cited by 22
G3BP1 Inhibition Alleviates Intracellular Nucleic Acid–Induced Autoimmune Responses
Cai, H., Liu, X., Zhang, F., Han, Q., Liu, Z.-S., Xue, W., Guo, Z.-L., Zhao, J., Sun, L.-M., Wang, N., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001111 · Cited by 22
Biochemical characterization of mRNA capping enzyme from Faustovirus
Chan, S., Molé, C. N., Nye, D. B., Mitchell, L., Dai, N., Buss, J., Kneller, D. W., Whipple, J. M., & Robb, G. B. (2023) · RNA · doi:10.1261/rna.079738.123 · Cited by 23
RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity
Smith, J. A., Braga, A., Verheyen, J., Basilico, S., Bandiera, S., Alfaro‐Cervelló, C., Peruzzotti‐Jametti, L., Shu, D., Haque, F., Guo, P., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.11.008 · Cited by 22
“In mammalian cells, the presence of uncapped 50-triphosphate (or diphosphate) groups on nucleic acids is a known PAMP, recognized in the cytosol by the RIG-I helicase as a probable viral infection and triggering a type I IFN inflammatory response.(91,92) Indeed, siRNA-3WJs retaining their 50-triphosphate groups provok…”
BackgroundToll-like Receptors in Viral Encephalitis
Gern, O. L., Mulenge, F., Pavlou, A., Ghita, L., Steffen, I., Stangel, M., & Kalinke, U. (2021) · Viruses · doi:10.3390/v13102065 · Cited by 24
Dynamic Evolution of Avian RNA Virus Sensors: Repeated Loss of RIG-I and RIPLET
Krchlíková, V., Hron, T., Těšičký, M., Li, T., Ungrová, L., Hejnar, J., Vinkler, M., & Elleder, D. (2022) · Viruses · doi:10.3390/v15010003 · Cited by 20
Aufgebauer, C. J., Bland, K. M., & Horner, S. M. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2023.12.004 · Cited by 24
An, W., Lakhina, S., Leong, J., Rawat, K., & Husain, M. (2024) · Pathogens · doi:10.3390/pathogens13070561 · Cited by 23
Stuart, J. D., Holm, G. H., & Boehme, K. W. (2018) · Journal of Virology · doi:10.1128/jvi.01947-17 · Cited by 21
Valdés‐López, J. F., Velilla, P. A., & Inchima, S. U. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2019.0058 · Cited by 21
Kang, Z., Yang, M., Liu, Y., Yang, G., Dong, Y., Zhou, H., Zhang, Z., Li, M., Fan, H., Li, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60123-7 · Cited by 21
“Previous studies had shown that viral RNA is crucial to activate RIG-I to trigger downstream signaling pathways 20,39,40 .”
A ribosomal RNA fragment with 2′,3′-cyclic phosphate and GTP-binding activity acts as RIG-I ligand
Jung, S., von Thülen, T., Yang, I., Laukemper, V., Rupf, B., Janga, H., Panagiotidis, G., Schoen, A., Nicolai, M., Schulte, L. N., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa739 · Cited by 21
Huang, H., Zhao, J., Wang, T., Zhang, S. J., Zhou, Y., Rao, Y., Qin, C., Liu, Y., Chen, Y., Xia, Z., et al. (2021) · mBio · doi:10.1128/mbio.00115-21 · Cited by 20
DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation
Pallett, M. A., Lu, Y., & Smith, G. L. (2022) · Viruses · doi:10.3390/v14020316 · Cited by 20
“IRF3 signalling is tightly regulated and is triggered by intracellular cytoplasmic/ endoplasmic detection of viral RNA (dsRNA/5′-ppp/pp-RNA) [3] and DNA by pattern recognition receptors (PRRs) [4].”
BackgroundLee, K.-Y., Craig, C., & Patel, S. S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1106 · Cited by 20
“RIG-I recognizes blunt-ended double-stranded ( ds ) RNAs with a 5 (cid:2) -triphosphate ( 5 (cid:2) ppp ) and 5 (cid:2) PP ( diphosphate ) , while MDA5 recognizes long dsRNA regions ( 4–8 ) .”
Rivera-Serrano, E. E., DeAngelis, N., & Sherry, B. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.08.008 · Cited by 19
Miyamoto, M., & Komuro, A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.048 · Cited by 20
siRNAs and piRNAs collaborate for transposon control in the two-spotted spider mite
Mondal, M., Mansfield, K. P., & Flynt, A. S. (2018) · RNA · doi:10.1261/rna.065839.118 · Cited by 21
Takahashi, T., & Ui‐Tei, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041348 · Cited by 20
Varghese, P. M., Kishore, U., & Rajkumari, R. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152279 · Cited by 19
RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma
Lambing, S., Tan, Y. P., Vasileiadou, P., Holdenrieder, S., Müller, P., Hagen, C., Garbe, S., Behrendt, R., Schlee, M., van den Boorn, J. G., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad001 · Cited by 22
“RIG-I is broadly expressed in nucleated cells, including tumour cells, and can be specifically activated by 5 ′ -tri- or 5 ′ -diphosphorylated, blunt-ended, doublestranded RNA ( dsRNA ) ( Hornung et al., 2006 ; Schlee et al., 2009 ; Goubau et al., 2014 ) .”
BackgroundO’Donovan, D. H., Mao, Y., & Mele, D. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190620103105 · Cited by 19
Yang, K., Dong, B., Asthana, A., Silverman, R. H., & Yan, N. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00187-1 · Cited by 18
“3 ’ cyclic phosphate RNA ends produced by metal-ion-independent endoribonucleases can also activate RIG-I (Jung et al, 2020; Shigematsu et al, 2018).”
InfluentialLINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
You, E., Patel, B. K., Rojas, A. S., Sun, S., Danaher, P. J., Ho, N. I., Phillips, I. E., Raabe, M. J., Song, Y., Xu, K. H., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1317 · Cited by 20
RNF144B negatively regulates antiviral immunity by targeting MDA5 for autophagic degradation
Li, G., Zhang, J., Zhao, Z., Wang, J., Li, J., Xu, W., Cui, Z., Sun, P., Yuan, H., Wang, T., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00256-w · Cited by 16
“RIG-I primarily detects viral 5-diphosphate (5 ′ pp) or 5 ′ -triphosphate (5 ′ ppp) of double-stranded RNA (dsRNA) and short dsRNA (Goubau et al, 2014; Hornung et al, 2006; Luo et al, 2011; Schlee et al, 2009).”
The intrinsically disordered CARDs‐Helicase linker in RIG‐I is a molecular gate for RNA proofreading
Schweibenz, B., Devarkar, S. C., Solotchi, M., Craig, C., Zheng, J., Pascal, B. D., Gokhale, S., Xie, P., Griffin, P. R., & Patel, S. S. (2022) · The EMBO Journal · doi:10.15252/embj.2021109782 · Cited by 18
“RIG-I recognizes short blunt-ended double-stranded (ds) RNAs with 5’-triphosphate (5’ppp), 5’-diphosphate (5’pp), and 5’-m7G cap as PAMPs (pathogen-associated molecular pattern) (Jiang et al , 2011; Goubau et al , 2014; Schuberth-Wagner et al , 2015; Devarkar et al , 2016).”
Liu, L., Nishikawa, T., & Kaneda, Y. (2015) · Molecular Therapy · doi:10.1038/mt.2015.201 · Cited by 18
Hou, G., Beatty, W. L., Ren, L., Ooi, Y. S., Son, J., Zhu, Y., Sheng, Q., Huang, W., Li, D., Liu, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59090-w · Cited by 16
“RIG-I preferentially binds to uncapped RNA bearing a triphosphate group 7 or a diphosphate group 8 , while MDA5 recognizes long dsRNA 9 .”
InfluentialHuman C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain
Varghese, P. M., Kishore, U., & Rajkumari, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063045 · Cited by 18
“For example, TLR3 is known to recognise dsRNA in endosomes and unfamiliar RNA structures that are present in phagocytosed cells infected with IAVs [29,30].”
BackgroundInfluentialCrosstalk between Autophagy and RLR Signaling
Ke, P. (2023) · Cells · doi:10.3390/cells12060956 · Cited by 17
The molecular language of RNA 5′ ends: guardians of RNA identity and immunity
Avila‐Bonilla, R. G., & Macías, S. (2024) · RNA · doi:10.1261/rna.079942.124 · Cited by 17
“Uncapped dsRNAs typically accumulate during the replication of ssRNA (+) or ( − ) strand viruses (Hornung et al. 2006; Pichlmair et al. 2006; Rehwinkel et al. 2010; Wang et al. 2010; Goubau et al. 2014; Ren et al. 2019).”
BackgroundCrosstalk between vault RNAs and innate immunity
Avila‐Bonilla, R. G., & Martínez-Montero, J. P. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09305-y · Cited by 17
“These transcription factors cooperate to initiate the expression of type I IFN and proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and IL-8 [12, 20–23].”
BackgroundNielsen, A. E., Hantho, J. D., & Mancini, R. J. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0101 · Cited by 17
Martin‐Vicente, M., Resino, S., & Martínez, I. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00793-3 · Cited by 18
Genetic determinants of host immunity against human rhinovirus infections
Lamborn, I. T., & Su, H. C. (2020) · Human Genetics · doi:10.1007/s00439-020-02137-3 · Cited by 17
Grudzinska‐Goebel, J., Braun, M., Chen, L., Gupta, S., Lohmann, S., Morais, P., Niu, T., Tarcsa, E., Tourdot, S., Youssef, A. S., et al. (2025) · Nucleic Acid Therapeutics · doi:10.1177/21593337251387423 · Cited by 17
Zebrafish prmt2 Attenuates Antiviral Innate Immunity by Targeting traf6
Zhu, J., Li, X., Sun, X., Zhou, Z., Cai, X., Liu, X., Wang, J., & Xiao, W. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100627 · Cited by 15
Early Events in Reovirus Infection Influence Induction of Innate Immune Response
Abad, A. T., & Danthi, P. (2022) · Journal of Virology · doi:10.1128/jvi.00917-22 · Cited by 15
“71 Reovirus infection triggers an innate immune response mediated by retinoic acid-inducible 72 gene-I (RIG-I) and melanoma-differentiation associated 5 (MDA5), which are members of the 73 RIG-I like receptor (RLR) family of proteins(16-20).”
BackgroundInfluentialMayaro virus infection elicits a robust pro-inflammatory and antiviral response in human macrophages
Hernández-Sarmiento, L. J., Tamayo-Molina, Y. S., Valdés‐López, J. F., & Inchima, S. U. (2024) · Acta Tropica · doi:10.1016/j.actatropica.2024.107146 · Cited by 14
Effective synthesis of circRNA via a thermostable T7 RNA polymerase variant as the catalyst
He, W., Zhang, X., Zou, Y., Li, J., Chang, L., He, Y.-C., Jin, Q., & Ye, J. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1356354 · Cited by 16
“…which may result in a strong immune response against RNA drugs, has been detected by researchers (Kato et al., 2006; Pichlmair et al., 2006; Goubau et al., 2014). dsRNA byproducts were produced at a proportion of 1.98 ± 0.04 ×10 – 4 of the total yield of RNA products catalyzed by T7 RNAP…”
BackgroundInfluentialAnchisi, S., Guerra, J., Mottet-Osman, G., & Garcin, D. (2015) · Journal of Virology · doi:10.1128/jvi.01671-15 · Cited by 15
Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease
Suarez, A. A. R., Testoni, B., Baumert, T. F., & Lupberger, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624034 · Cited by 18
Harnessing the Activation of RIG-I Like Receptors to Inhibit Glioblastoma Tumorigenesis
Bufalieri, F., Basili, I., Marcotullio, L. D., & Infante, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.710171 · Cited by 14
“…double-strand RNAs (dsRNAs), single-strand RNAs (ssRNAs) forming secondary structure (i.e., hairpin or panhandle conformations), and RNAs with uncapped diphosphate (PP) groups at the 5′ (Hornung et al., 2006; Pichlmair et al., 2006; Schmidt et al., 2009; Schlee, 2013; Goubau et al., 2014).”
BackgroundDu, X., Pan, T., Xu, J. C., Zhang, Y., Song, W., Yi, Z., & Yuan, Z. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000607 · Cited by 15
A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA
de Regt, A. K., Anand, K., Ciupka, K., Bender, F., Gatterdam, K., Putschli, B., Fußhöller, D. M., Hilbig, D., Kirchhoff, A., Hunkler, C., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad835 · Cited by 14
Zhu, C., Liu, W., Jia, S., Sun, X., Wang, Z., Deng, H., Bai, Y., Xiao, W., & Liu, X. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.740871 · Cited by 13
m6A Methylation in Regulation of Antiviral Innate Immunity
Karandashov, I., Kostyusheva, A., Kachanov, A., Dukich, M., Ponomareva, N., Brezgin, S., Lukashev, A., Pokrovsky, V. S., Chulanov, V., & Kostyushev, D. S. (2024) · Viruses · doi:10.3390/v16040601 · Cited by 15
“RIG-I recognizes relatively short ssRNA and dsRNA (up to 1 kb) with triphosphate or diphosphate fragments at the 5 ′ -end [70].”
BackgroundInnate Sensing of Viral Nucleic Acids and Their Use in Antiviral Vaccine Development
Enya, T., & Ross, S. R. (2025) · Vaccines · doi:10.3390/vaccines13020193 · Cited by 15
“In contrast, MDA5 detects long dsRNA generated during RNA virus replication, as well as synthetic RNAs, including poly I:C; the recognition of dsRNA by MDA5 activates IRF3 and NF κ B, also leading to increased production of IFN-I [109,110] (Figure 2).”
Molecular cloning and functional characterization of feline MAVS
Wu, H., Zhang, X., Liu, C., Liu, D., Liu, J., Wang, G., Tian, J., & Qu, L. (2015) · Immunologic Research · doi:10.1007/s12026-015-8682-9 · Cited by 15
Innate sensing of mRNA vaccines
Wuebben, C., Bartok, E., & Hartmann, G. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102249 · Cited by 16
How Many Mammalian Reovirus Proteins are involved in the Control of the Interferon Response?
Lanoie, D., Boudreault, S., Bisaillon, M., & Lemay, G. (2019) · Pathogens · doi:10.3390/pathogens8020083 · Cited by 14
“(PAMP) recognized by RIG-I [13]; however, again, it is not clear if these ends are actually exposed in the”
BackgroundInfluentialThe Reovirus σ3 Protein Inhibits NF-κB-Dependent Antiviral Signaling
McNamara, A. J., Brooks, A. D., & Danthi, P. (2022) · Journal of Virology · doi:10.1128/jvi.00515-22 · Cited by 13
Huang, S., Huang, Y., Su, T., Huang, R., Su, L., Wu, Y., Weng, S., He, J., & Xie, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04532-22 · Cited by 13
“Lots of research on RIG-I agonists indicated that RIG-I plays a key role in the recognition of RNA viruses including Sendai virus (SeV) (39, 40), reovirus (41), vesicular stomatitis virus (42), Newcastle disease virus (43), and influenza virus (44).”
BackgroundHost Immune Response to Dengue Virus Infection: Friend or Foe?
Dhole, P., Zaidi, A., Nariya, H. K., Sinha, S., Jinesh, S., & Srivastava, S. (2024) · Immuno · doi:10.3390/immuno4040033 · Cited by 15
“…and prevents mitochondrial DNA sensing [135,136] These cells possess pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns (PAMPs) that include double-stranded or single-stranded RNA and diphosphate structures generated during virus replication [140–143].”
IKKε isoform switching governs the immune response against EV71 infection
Chang, Y., Liao, Y., Chen, M., Chang, S., Huang, Y., Ho, B., & Yu, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02187-x · Cited by 13
Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
Twilhaar, M. K. N., Czentner, L., van Nostrum, C. F., Storm, G., & den Haan, J. M. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070954 · Cited by 13
The Role of RNA Editing in the Immune Response
Ahmad, S., Mu, X. N., & Hur, S. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0787-9_17 · Cited by 12
Tossberg, J. T., Esmond, T., & Aune, T. M. (2020) · BioTechniques · doi:10.2144/btn-2020-0037 · Cited by 13
Proofreading mechanisms of the innate immune receptor RIG-I: distinguishing self and viral RNA
Solotchi, M., & Patel, S. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230724 · Cited by 12
Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes
Issa, W., Njeim, R., Carrazco, A., Burke, G. W., & Mitrofanova, A. V. (2024) · Cells · doi:10.3390/cells13131157 · Cited by 13
“In addition to the 5 ′ -triphosphate structure, the 5 ′ -diphosphate moiety can also be recognized by RIG-I [96].”
BackgroundEndosomes serve as signaling platforms for RIG-I ubiquitination and activation
Chen, K., Yang, C.-Y., Shu, S.-G., Lo, Y.-C., Lee, K.-W., Wang, L.-C., Chen, J.-B., Shih, M.-C., Chang, H.-C., Hsiao, Y.-J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq0660 · Cited by 12
“Notably, RIG-I preferentially recognizes 5 ′ - triphosphate (PPP) or 5 ′ - diphosphate–containing double-stranded RNAs, while MDA5 binds to long double-stranded RNA (dsRNA) lacking 2 ′ - O-methylation at the 5 ′ cap ( 7 – 9 ).”
Identification of a second binding site on the TRIM25 B30.2 domain
D’Cruz, A. A., Kershaw, N. J., Hayman, T. J., Linossi, E. M., Chiang, J. J., Wang, M. K., Dagley, L. F., Kolesnik, T. B., Zhang, J., Masters, S. L., et al. (2017) · Biochemical Journal · doi:10.1042/bcj20170427 · Cited by 12
Loss of IKK Subunits Limits NF-κB Signaling in Reovirus-Infected Cells
McNamara, A. J., & Danthi, P. (2020) · Journal of Virology · doi:10.1128/jvi.00382-20 · Cited by 12
Epigenetic regulation of RNA sensors: Sentinels of immune response
Khan, M. I., Nur, S. M., Adhami, V. M., & Mukhtar, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.028 · Cited by 12
Chen, X., Fan, S., Zhu, C., Liao, Q., Tang, J., Yu, G., Cai, X., Ouyang, G., Xiao, W., & Liu, X. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100983 · Cited by 13
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and developmentPreprint
Alexander, S., Armstrong, J. F., Davenport, A. P., Davies, J. A., Faccenda, E., Harding, S. D., Levi‐Schaffer, F., Pawson, A. J., Southan, C., & Spedding, M. (2020) · doi:10.22541/au.158679935.58510327 · Cited by 12
Research progress of mRNA vaccines for infectious diseases
Zhang, Z., Du, J., Zhang, D., Han, R., Wu, X., & Liang, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-03060-x · Cited by 19
Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors
Wang, S., Xu, X., Viitala, T., Shu, Y., & Zhang, H. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102737 · Cited by 14
Hong, S., Kim, J. Y., Kim, H., Kim, D., Won, T., Han, D. H., Rhee, C., & Kim, H. J. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.08.017 · Cited by 11
The intersection molecule MDA5 in Cancer and COVID-19
Jin, R., Cao, X., Lu, M., Gao, Q. S., & Ma, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963051 · Cited by 11
Initial activation of STAT2 induced by IAV infection is critical for innate antiviral immunity
Li, X., Liu, S., Rai, K. R., Zhou, W., Wang, S., Chi, X., Guo, G., Chen, J., & Liu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960544 · Cited by 12
Effective Synthesis of High-Integrity mRNA Using In Vitro Transcription
He, W., Zhang, X., Zou, Y., Li, J., Wang, C., He, Y.-C., Jin, Q., & Ye, J. (2024) · Molecules · doi:10.3390/molecules29112461 · Cited by 13
“Nevertheless, the activation of pattern recognition receptors (RIG-I, MDA5 and so on) by dsRNA has adverse consequences, including the inhibition of protein synthesis and cell death, which can impact the efficacy of mRNA therapy [23–25].”
BackgroundViral RNA capping: Mechanisms and antiviral therapy
Chen, S., Jiang, Z., Li, Q., Pan, W., Chen, Y., & Liu, J. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29622 · Cited by 10
“I, struggles to recognize Cap 1, 92 aligning with the viral mRNA's Cap 1 structure evading the immunosuppressive effects of IFITs.”
BackgroundKumar, A., & Satpati, P. (2018) · ACS Omega · doi:10.1021/acsomega.7b02019 · Cited by 10
Innate Immune Stimulation in Cancer Therapy
Duewell, P., Heidegger, S. M., & Kobold, S. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.12.002 · Cited by 10
Oosenbrug, T., van den Wollenberg, D. J. M., Duits, E. W., Hoeben, R. C., & Ressing, M. E. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.140 · Cited by 10
Re-Examining Rotavirus Innate Immune Evasion: Potential Applications of the Reverse Genetics System
Antia, A., Pinski, A. N., & Ding, S. (2022) · mBio · doi:10.1128/mbio.01308-22 · Cited by 10
Sensing infection and tissue damage
Sousa, C. R. E. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607227 · Cited by 11
Genetic variants in RIG-I-like receptor influences HCV clearance in Chinese Han population
Wu, X., Zang, F., Liu, M., Zhuo, L., Wu, J., Xia, X., Feng, Y., Yu, R., Huang, P., & Yang, S. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819000827 · Cited by 10
“Environment, viral and host factors have been proved to be the influential factor in HCV spontaneous clearance and treatment response [4].”
BackgroundSignal‐transducing innate receptors in tumor immunity
Hangai, S., Kimura, Y., Taniguchi, T., & Yanai, H. (2021) · Cancer Science · doi:10.1111/cas.14848 · Cited by 12
Jiang, Z., Cheng, X., Sun, Z., Hu, J., Xu, X., Li, M., Feng, Z., & Hu, C. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104351 · Cited by 10
PLAAT1 inhibits type I interferon response via degradation of IRF3 and IRF7 in Zebrafish
Zhao, X., Huang, W., Shi, Y., Guo, J., Xiao, H., Ji, N., Feng, J., Dang, H., & Zou, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.979919 · Cited by 10
RIGulation of STING expression: at the crossroads of viral RNA and DNA sensing pathways
Liu, Y., Lin, R., & Olagnier, D. P. (2017) · Inflammation and Cell Signaling · doi:10.14800/ics.1491 · Cited by 10
“Among which, RIG-I specifically recognizes short dsRNA bearing a 5′ end diphosphate or triphosphate group (5′pp or 5′ppp) [18, 19].”
BackgroundKozlovski, I., Jaimes‐Becerra, A., Sharoni, T., Lewandowska, M., Karmi, O., & Moran, Y. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012320 · Cited by 9
“…vertebrates, poly(I: C), which mimics dsRNA, binds to and triggers the activation of the RNA sensors PKR, OAS1, TLR3, MDA5 and RIG-I, and consequently poly(I:C) or its derivatives have been used as a tool to identify and characterize dsRNA recognition receptors and ligand requirements [38,99– 103].”
Method5′ terminal nucleotide determines the immunogenicity of IVT RNAs
Wołczyk, M., Szymański, J., Trus, I., Naz, Z., Tame, T., Bolembach, A. A., Choudhury, N. R., Kasztelan, K., Rappsilber, J., Dziembowski, A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1252 · Cited by 9
“The most potent activators of RIG-I are short, blunt, double-stranded RNAs (dsRNAs) capped with 5 (cid:2) -ppp or 5 (cid:2) - pp moieties ( 8–11 ).”
RNA innate immunity constitutes a barrier for interspecies chimerism
Hu, Y., Sun, H., Sakurai, M., Luo, Z., Jones, A. E., Cheng, T., Huang, J., Liu, L., Zheng, C., Li, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.10.039 · Cited by 16
Li, H., Guo, Y., Qi, W., & Liao, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1031200 · Cited by 12
Advances in transposable elements: from mechanisms to applications in mammalian genomics
Han, M., Perkins, M. H., Novaes, L. S., Xu, T., & Chang, H. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1290146 · Cited by 9
Fayed, B. E., Shakartalla, S. B., Sabbah, H., Dalle, H., Tannira, M., Senok, A. C., & Soliman, S. S. M. (2024) · Mycopathologia · doi:10.1007/s11046-024-00868-9 · Cited by 9
“RIG-I-like receptor is one of the pathogen-specific pattern recognition receptors that can recognize the pathogen-specific 5 ′ -di or -triphospate RNA [93].”
Shah, N. K., Beckham, S. A., Wilce, J. A., & Wilce, M. C. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1307 · Cited by 9
“RIG-I senses dsRNA with a 5′ppp or 5′pp with high affinity (2,35), but shows only weak affinity for dsRNA with a 5′p (35).”
BackgroundLee, J. H., Park, E.-B., Min, J., Sung, S.-E., Jang, Y., Shin, J. S., Chun, D., Kim, K., Hwang, J., Lee, M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky039 · Cited by 9
“RIG-I recognizes dsRNAs containing uncapped 5′-PPP (11) or 5′-PP (12) which are found in RNA virus genomes and therefore produced during viral replication.”
BackgroundRetractedLi, N., Li, A., ZHENG, K. C., Liu, X., Gao, L., Liu, D., Deng, H., Wu, W., Liu, B., Zhao, B., et al. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.10.007 · Cited by 9
Yong, H. Y., Zheng, J., Ho, V. C. Y., Nguyen, M. T., Fink, K., Griffin, P. R., & Luo, D. (2019) · FEBS Letters · doi:10.1002/1873-3468.13564 · Cited by 9
Innate immune sensors for detecting nucleic acids during infection
Ghoreshi, Z., Nakhaee, M., Samie, M., Zak, M. S., & Arefinia, N. (2022) · Journal of Laboratory Medicine · doi:10.1515/labmed-2021-0173 · Cited by 8
“RIG-I is also triggered by the 5ʹ end of triphosphorylation or 5ʹ diphosphorylated short dsRNAs [15, 16].”
BackgroundSchwab, L. S. U., Londrigan, S. L., Brööks, A. G., Hurt, A. C., Sahu, A., Deng, Y., Moselen, J. M., Coch, C., Zillinger, T., Hartmann, G., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00559-22 · Cited by 8
Zebrafish mavs Is Essential for Antiviral Innate Immunity
Ouyang, G., Liao, Q., Fan, S., Cai, X., Wang, J., Liu, X., & Xiao, W. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200126 · Cited by 8
mRNA vaccines against infectious diseases and future direction
Aleem, M. T., Munir, F., Shakoor, A., & Gao, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112320 · Cited by 10
Porcine epidemic diarrhea virus nsp14 inhibited IFN-Ⅰ production by targeting RIG-I for degradation
Li, S., Wang, L., Wen, Y., Han, J., Hou, J., Hou, Z., Xie, J., Li, H., Li, X., Yang, Y., et al. (2025) · Virology · doi:10.1016/j.virol.2025.110451 · Cited by 8
RNF19a inhibits antiviral immune response to RNA viruses through degradation of TBK1
Yang, Y., Cao, X., Huang, L., & Yang, A. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2021.12.021 · Cited by 8
Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
Xie, B., & Luo, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.903781 · Cited by 9
“…until now, chemotherapy and radiotherapy have remained the important treatment options for a variety of cancers (Hellmann et al., 2016; Chu et al., 2018; Qin et al., 2018; De Ruysscher et al., 2019; Grassberger et al., 2019; Galluzzi et al., 2020; Huang and Zhou, 2020; McLaughlin et al., 2020).”
Background
Metadata
- Authors
- Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., Iskarpatyoti, J. A., Barchet, W., Ludwig, J., Dermody, T. S., Hartmann, G., & Reis e Sousa, C.
- Affiliations
- Cancer Research UK (GB)
- University Hospital Bonn (DE)
- Vanderbilt University (US)
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Goubau, Delphine
- ORCID
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7522
- Pages
- 372-375
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4201573
- OpenAlex
- W2156869719
- Cited by
- 557
- References
- 36
- Citations by year
- 2026: 16 · 2025: 40 · 2024: 43 · 2023: 34 · 2022: 54 · 2021: 56 · 2020: 51 · 2019: 51 · 2018: 62 · 2017: 44 · 2016: 43 · 2015: 55 · 2014: 8
- FWCI
- 22.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Cancer Research UK (15689, A3598)
- National Institute of Allergy and Infectious Diseases (R01AI038296, R37AI038296, R01AI050800)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- RIG-I, antiviral innate immunity, RIG-I-like receptors, MDA5, MAVS, type I interferon, reovirus, L-A virus, viral RNA recognition, self/non-self discrimination, cytosolic RNA sensing, RNA-dependent protein kinase, interferon-stimulated genes, interferon lambda
- MeSH terms
- DEAD Box Protein 58, Animals, Base Sequence, Female, Immunity, Innate, Male, Diphosphates, Reoviridae, RNA, Viral, Genome, Viral, Base Pairing, Mice, DEAD-box RNA Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review